Darrin Smith - 01 Jan 2026 Form 3 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Reporting relationship: Executive VP, CIO & Secretary
Issuer ticker: SBRA
Reported as of: 01 Jan 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 12 Jan 2026, 19:06:40 UTC
Next SEC filing: 12 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Costa, as Attorney-in-Fact

Key filing fact

Darrin Smith filed Form 3 for Sabra Health Care REIT, Inc. (SBRA) on 12 Jan 2026.

Key facts

This page summarizes Darrin Smith's Form 3 filing for Sabra Health Care REIT, Inc. (SBRA).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Jan 2026, 19:06.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002104848 Primary reporting owner

Smith Darrin

Relationship: Executive VP, CIO & Secretary
Address: C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN
Signature: /s/ Michael Costa, as Attorney-in-Fact
Signature date: 12 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 101,876
Date: 01 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 44,034 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .